
Occidental Petroleum (NYSE:OXY) is repositioning its portfolio and accelerating upstream development following the announced $9.7 billion sale of its OxyChem segment to Berkshire Hathaway (NYSE:BRK) (NYSE:BRK).
The transaction, expected to close by year-end, underscores management’s strategy to reduce debt, reallocate capital, and pursue opportunistic shareholder returns, JPMorgan analysts led by Arun Jayaram noted in a recent report.